{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:28:48Z","timestamp":1786325328203,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","award":["2021ZQNZD004"],"award-info":[{"award-number":["2021ZQNZD004"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117067","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:23:07Z","timestamp":1782858187000},"page":"117067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of the Caspase-9\/GSDME axis by Auranofin: a potential therapeutic strategy for bacterial toxin-mediated severe systemic disease"],"prefix":"10.1016","volume":"186","author":[{"given":"Xingchen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2026.117067_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.intimp.2026.117067_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13050306","article-title":"Shiga toxin-associated Hemolytic uremic syndrome: specificities of adult patients and implications for critical care management","volume":"13","author":"Travert","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2026.117067_bb0015","series-title":"Hemolytic Uremic Syndrome, StatPearls, Treasure Island (FL)","author":"Bhandari","year":"2026"},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15010010","article-title":"Diagnosis and treatment for Shiga toxin-producing Escherichia coli associated hemolytic uremic syndrome","volume":"15","author":"Liu","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"9","key":"10.1016\/j.intimp.2026.117067_bb0025","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-020-04560-0","article-title":"Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome","volume":"35","author":"Ylinen","year":"2020","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-025-09369-x","article-title":"Genomics of Shiga toxin-producing Escherichia coli from asymptomatic carriers in Japan highlights risk-adaptive control","volume":"9","author":"Imai","year":"2025","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117067_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17060282","article-title":"INM004: polyclonal neutralizing antibodies against Shiga toxin as a treatment for hemolytic uremic syndrome","volume":"17","author":"Rivas","year":"2025","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2026.117067_bb0040","first-page":"105","article-title":"Shiga toxin pathogenesis: kidney complications and renal failure","volume":"357","author":"Obrig","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.intimp.2026.117067_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1736204","article-title":"Eliglustat prevents acute kidney injury caused by Shiga toxin 2 in lethal and sublethal rat models of hemolytic uremic syndrome","volume":"17","author":"Sanchez","year":"2026","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117067_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","article-title":"Insights on the crosstalk among different cell death mechanisms","volume":"11","author":"Eskander","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117067_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/Pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0065","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat. Commun."},{"issue":"7661","key":"10.1016\/j.intimp.2026.117067_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.117067_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41419-019-1441-4","article-title":"Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.117067_bb0080","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1074\/jbc.M204783200","article-title":"Regulation of the Apaf-1\/caspase-9 apoptosome by caspase-3 and XIAP","volume":"278","author":"Zou","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.117067_bb0085","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acsnano.1c08913","article-title":"Intrinsic radical species scavenging activities of tea polyphenols nanoparticles block Pyroptosis in endotoxin-induced Sepsis","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"issue":"Pt B","key":"10.1016\/j.intimp.2026.117067_bb0090","article-title":"Caspase-3\/GSDME mediated pyroptosis: a potential pathway for sepsis","volume":"124","author":"Jiao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117067_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molimm.2024.06.007","article-title":"Inhibiting caspase-3\/GSDME-mediated pyroptosis ameliorates septic lung injury in mice model","volume":"172","author":"Qin","year":"2024","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117067_bb0100","first-page":"4287","article-title":"Inhibition of caspase-3-mediated GSDME-derived pyroptosis aids in noncancerous tissue protection of squamous cell carcinoma patients during cisplatin-based chemotherapy","volume":"10","author":"Huang","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117067_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41419-021-03458-5","article-title":"Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity","volume":"12","author":"Shen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117067_bb0110","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2507.07048","article-title":"Drug repurposing: an emerging strategy in Staphylococcus aureus infections","volume":"35","author":"Li","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2026.117067_bb0115","article-title":"Auranofin: past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"19","key":"10.1016\/j.intimp.2026.117067_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells14191541","article-title":"Auranofin ameliorates gouty inflammation by suppressing NLRP3 activation and neutrophil migration via the IL-33\/ST2-CXCL1 Axis","volume":"14","author":"Yoo","year":"2025","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.intimp.2026.117067_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052084","article-title":"Inhibition of thioredoxin-reductase by auranofin as a pro-oxidant anticancer strategy for glioblastoma: in vitro and in vivo studies","volume":"26","author":"Chmelyuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0340023","article-title":"Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage","volume":"21","author":"Shimoda","year":"2026","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.intimp.2026.117067_bb0135","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/1078-0432.CCR-18-2751","article-title":"Auranofin protects intestine against radiation injury by modulating p53\/p21 pathway and radiosensitizes human colon tumor","volume":"25","author":"Nag","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117067_bb0140","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.18632\/oncotarget.6516","article-title":"Auranofin-mediated inhibition of PI3K\/AKT\/mTOR axis and anticancer activity in non-small cell lung cancer cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.intimp.2026.117067_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050439","article-title":"Advances and challenges in sepsis management: modern tools and future directions","volume":"13","author":"Santacroce","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.intimp.2026.117067_bb0150","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117067_bb0155","doi-asserted-by":"crossref","DOI":"10.5492\/wjccm.v14.i4.105547","article-title":"Sepsis and the diverse organ-gastrointestinal tract axis","volume":"14","author":"Wang","year":"2025","journal-title":"World J. Crit. Care Med."},{"key":"10.1016\/j.intimp.2026.117067_bb0160","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3389\/fimmu.2020.01918","article-title":"The critical roles and mechanisms of immune cell death in sepsis","volume":"11","author":"Cheng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117067_bb0165","article-title":"Shiga toxin induces apoptosis via ROS-caspase activation in human cerebral endothelial cell line hCMEC\/D3 and astrocyte co-culture","volume":"36","author":"Kim","year":"2026","journal-title":"J. Microbiol. Biotechnol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117067_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136884","article-title":"Enterohemorrhagic Escherichia coli and a fresh view on Shiga toxin-binding glycosphingolipids of primary human kidney and Colon epithelial cells and their toxin susceptibility","volume":"23","author":"Detzner","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2026.117067_bb0175","article-title":"The many lives of auranofin: how an old anti-rheumatic agent may become a promising antimicrobial drug","volume":"13","author":"Coscione","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2026.117067_bb0185","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"4","key":"10.1016\/j.intimp.2026.117067_bb0190","first-page":"507","article-title":"Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages, cell","volume":"24","author":"Taabazuing","year":"2017","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117067_bb0195","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.41963","article-title":"Attenuation of rheumatoid arthritis through the inhibition of tumor necrosis factor-induced caspase 3\/gasdermin E-mediated pyroptosis","volume":"74","author":"Zhai","year":"2022","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-022-00848-2","article-title":"Blocking GSDME-mediated pyroptosis in renal tubular epithelial cells alleviates disease activity in lupus mice","volume":"8","author":"Luo","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117067_bb0205","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2147\/DMSO.S515034","article-title":"Inhibition of Caspase-3\/GSDME pathway-mediated pyroptosis of renal tubular epithelial cells by dagliflozin in the pathogenesis of diabetic kidney disease and study of its mechanism","volume":"18","author":"Jiang","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.intimp.2026.117067_bb0210","article-title":"Mini-review: GSDME-mediated pyroptosis in diabetic nephropathy","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117067_bb0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.117067_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2026.113315","article-title":"Anticancer gold complexes: controlled activation, precision targeting and beyond","volume":"280","author":"Wang","year":"2026","journal-title":"J. Inorg. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2026.117067_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115920","article-title":"Anti-inflammatory effect of auranofin on palmitic acid and LPS-induced inflammatory response by modulating TLR4 and NOX4-mediated NF-kappaB Signaling pathway in RAW264.7 macrophages","volume":"22","author":"Hwangbo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117067_bb0230","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s42003-021-02345-1","article-title":"Auranofin prevents liver fibrosis by system xc-mediated inhibition of NLRP3 inflammasome","volume":"4","author":"Kim","year":"2021","journal-title":"Commun. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117067_bb0235","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4103\/0366-6999.205865","article-title":"Sepsis and intestinal microvascular endothelial dysfunction","volume":"130","author":"Chen","year":"2017","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.intimp.2026.117067_bb0240","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","article-title":"Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond","volume":"57","author":"Dho","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2026.117067_bb0245","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1531-8249(199906)45:6<716::AID-ANA5>3.0.CO;2-N","article-title":"Brainstem mechanisms of autonomic dysfunction in encephalopathy-associated Shiga toxin 2 intoxication","volume":"45","author":"Yamada","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.117067_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.825856","article-title":"Therapeutic antibodies against Shiga toxins: trends and perspectives","volume":"12","author":"Henrique","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:41:29Z","timestamp":1786322489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S1567576926009136"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117067","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the Caspase-9\/GSDME axis by Auranofin: a potential therapeutic strategy for bacterial toxin-mediated severe systemic disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117067"}}